Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 10, 2026

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor
08:22

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor

Published on: October 9, 2017

Primate models for cardiovascular drug research and development.

You-Tang Shen1

  • 1University of Pennsylvania, Department of Medicine, Glenolden Research Laboratories, 500 South Ridgeway Avenue, Glenolden, PA 19036, USA. you-tang.shen@uphs.upenn.edu

Current Opinion in Investigational Drugs (London, England : 2000)
|August 24, 2010
PubMed
Summary

Non-human primate models offer superior translation for drug R&D due to human biological similarity. A novel primate model of heart failure allows continuous study of progressive cardiac disease, improving cardiovascular research.

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular Matrix Disarray as a Mechanism for Greater Abdominal Versus Thoracic Aortic Stiffness With Aging in Primates.

Arteriosclerosis, thrombosis, and vascular biology·2016
Same author

GLP-1 (7-36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles.

Cardiovascular diabetology·2014
Same author

Smooth muscle myosin inhibition: a novel therapeutic approach for pulmonary hypertension.

PloS one·2012
Same author

Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.

Science (New York, N.Y.)·2011
Same author

Preemptive conditioning of the swine heart by H11 kinase/Hsp22 provides cardiac protection through inducible nitric oxide synthase.

American journal of physiology. Heart and circulatory physiology·2011
Same author

Molecular mechanisms mediating preconditioning following chronic ischemia differ from those in classical second window.

American journal of physiology. Heart and circulatory physiology·2010

Area of Science:

  • Cardiovascular Research
  • Translational Medicine
  • Non-human Primate Models

Background:

  • Drug R&D often fails due to poor translation from animal models to human disease, stemming from species-specific biological differences.
  • Non-human primates (NHPs) exhibit significant physiological, metabolic, biochemical, and genetic similarities to humans, making them valuable research models.
  • There is a notable lack of NHP models for studying prevalent cardiovascular diseases like chronic myocardial ischemia and heart failure.

Purpose of the Study:

  • To describe a non-human primate model that accurately replicates the human cardiomyopathic process.
  • To highlight the utility of this NHP model for studying progressive heart failure stages.
  • To review other NHP models relevant to cardiovascular drug research and development.

Main Methods:

Related Experiment Videos

Last Updated: Jun 10, 2026

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor
08:22

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor

Published on: October 9, 2017

  • Development and characterization of a novel non-human primate model for induced heart failure.
  • Longitudinal monitoring of disease progression, including myocardial ischemia and left ventricular remodeling.
  • Comparative analysis of the primate model's pathology with human heart failure conditions.

Main Results:

  • The described primate model closely mimics the cardiomyopathic process observed in human heart failure.
  • This model enables continuous study throughout progressive stages, from ischemia to end-stage congestive heart failure.
  • The model provides a valuable platform for investigating mechanisms and potential therapies for heart failure.

Conclusions:

  • Non-human primate models, particularly the described heart failure model, offer significant advantages for cardiovascular drug R&D.
  • This model facilitates a more accurate translation of preclinical findings to human clinical outcomes.
  • Further utilization of NHP models is recommended to advance the understanding and treatment of cardiovascular diseases.